Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2015 Oct 7;10(10):1705-7.
doi: 10.2215/CJN.09120815. Epub 2015 Sep 25.

Cardiorenal Resynchronization Therapy: Strengthening the Heart and Kidneys

Edmond K Obeng-Gyimah  1 , Rajat Deo  2
Affiliations
Editorial

Cardiorenal Resynchronization Therapy: Strengthening the Heart and Kidneys

Edmond K Obeng-Gyimah et al. Clin J Am Soc Nephrol. .
No abstract available

Keywords: chronic kidney disease; echocardiography; electrophysiology; heart failure.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Conceptual model linking cardiac resynchronization to an improvement in eGFR and clinical outcomes. CV, cardiovascular; LV, left ventricular; RAAS, renin-angiotensin-aldosterone system.
See this image and copyright information in PMC

Comment on

  • Cardiac Resynchronization Therapy in CKD Stage 4 Patients.
    Höke U, Khidir MJ, van der Velde ET, Schalij MJ, Bax JJ, Delgado V, Marsan NA. Höke U, et al. Clin J Am Soc Nephrol. 2015 Oct 7;10(10):1740-8. doi: 10.2215/CJN.00620115. Epub 2015 Sep 25. Clin J Am Soc Nephrol. 2015. PMID: 26408549 Free PMC article.

References

    1. Ezekowitz J, McAlister FA, Humphries KH, Norris CM, Tonelli M, Ghali WA, Knudtson ML; APPROACH Investigators: The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease. J Am Coll Cardiol 44: 1587–1592, 2004 - PubMed
    1. McAlister FA, Ezekowitz J, Tonelli M, Armstrong PW: Renal insufficiency and heart failure: Prognostic and therapeutic implications from a prospective cohort study. Circulation 109: 1004–1009, 2004 - PubMed
    1. Al-Ahmad A, Rand WM, Manjunath G, Konstam MA, Salem DN, Levey AS, Sarnak MJ: Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. J Am Coll Cardiol 38: 955–962, 2001 - PubMed
    1. Hillege HL, Nitsch D, Pfeffer MA, Swedberg K, McMurray JJV, Yusuf S, Granger CB, Michelson EL, Östergren J, Cornel JH, de Zeeuw D, Pocock S, van Veldhuisen DJ; Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Investigators: Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation 113: 671–678, 2006 - PubMed
    1. Harnett JD, Foley RN, Kent GM, Barre PE, Murray D, Parfrey PS: Congestive heart failure in dialysis patients: Prevalence, incidence, prognosis and risk factors. Kidney Int 47: 884–890, 1995 - PubMed